These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10892157)

  • 1. [Should routines for fetal trisomy screening be changed?].
    Jouppila P
    Duodecim; 1997; 113(24):2493-5. PubMed ID: 10892157
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antenatal screening methods for chromosome 21 trisomy].
    Päkkilä M; Niemimaa M; Kirkinen P; Ryynänen M
    Duodecim; 2001; 117(3):269-74; quiz 274, 281. PubMed ID: 12092395
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fetal trisomy 21 risk evaluation by measurement of maternal serum markers].
    Dhondt JL
    Ann Biol Clin (Paris); 1998; 56(4):471-5. PubMed ID: 9754284
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrences of free trisomy 21: analysis of data from the National Down Syndrome Cytogenetic Register.
    Morris JK; Mutton DE; Alberman E
    Prenat Diagn; 2005 Dec; 25(12):1120-8. PubMed ID: 16231400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical concerns and future directions in maternal screening for Down syndrome.
    Elkins TE; Brown D
    Womens Health Issues; 1995; 5(1):15-20. PubMed ID: 7742644
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prenatal screening for Down syndrome: from sequential to combined estimated risk].
    Jouannic JM; Benifla JL
    Gynecol Obstet Fertil; 2006 Jun; 34(6):467-9. PubMed ID: 16716636
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of record linkage for auditing the uptake and outcome of prenatal serum screening and prenatal diagnostic tests for Down syndrome.
    Alberman E; Huttly W; Hennessy E; McIntosh A
    Prenat Diagn; 2003 Oct; 23(10):801-6. PubMed ID: 14558023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA; Ying J; Beazoglou T; Egan JF
    Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18.
    Jaques AM; Halliday JL; Francis I; Bonacquisto L; Forbes R; Cronin A; Sheffield LJ
    BJOG; 2007 Jul; 114(7):812-8. PubMed ID: 17501960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential pathways of testing after first-trimester screening for trisomy 21.
    Platt LD; Greene N; Johnson A; Zachary J; Thom E; Krantz D; Simpson JL; Silver RK; Snijders RJ; Goetzl L; Pergament E; Filkins K; Mahoney MJ; Hogge WA; Wilson RD; Mohide P; Hershey D; MacGregor S; Bahado-Singh R; Jackson LG; Wapner R;
    Obstet Gynecol; 2004 Oct; 104(4):661-6. PubMed ID: 15458882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal diagnosis of trisomy 21: registration results from a single genetic center.
    Witters I; Fryns JP
    Genet Couns; 2008; 19(2):157-63. PubMed ID: 18618989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester screening for Down syndrome in multiple pregnancy.
    Cleary-Goldman J; Berkowitz RL
    Semin Perinatol; 2005 Dec; 29(6):395-400. PubMed ID: 16533653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
    Biggio JR; Morris TC; Owen J; Stringer JS
    Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The triple test decision.
    Grayson A
    Mod Midwife; 1996 Aug; 6(8):16-9. PubMed ID: 8974672
    [No Abstract]   [Full Text] [Related]  

  • 15. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing for Down syndrome in the older woman: a risky business?
    Hodges RJ; Wallace EM
    Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):486-8. PubMed ID: 16401213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Karyotypes found in the population declared at increased risk of Down syndrome following maternal serum screening.
    Ryall RG; Callen D; Cocciolone R; Duvnjak A; Esca R; Frantzis N; Gjerde EM; Haan EA; Hocking T; Sutherland G; Thomas DW; Webb F
    Prenat Diagn; 2001 Jul; 21(7):553-7. PubMed ID: 11494290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of the ethics of informed consent for first-trimester risk assessment for trisomy 21.
    Chervenak FA; McCullough LB; Chasen ST
    Semin Perinatol; 2005 Aug; 29(4):277-9. PubMed ID: 16104682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester tests for trisomies 21 and 18 as sensitive as triple screen.
    Lewis PR; Pasalio R
    J Fam Pract; 2004 Mar; 53(3):184-6. PubMed ID: 15000919
    [No Abstract]   [Full Text] [Related]  

  • 20. An audit of the detection of trisomy 18 in prenatal screening for Down syndrome using the Combined test.
    Huttly WJ; Wald NJ
    Prenat Diagn; 2011 Dec; 31(13):1317. PubMed ID: 22028145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.